Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients With Advanced Cancer
Summary
The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.
Detailed description
Pain, fatigue, and distress are highly prevalent, co-occurring, and interfering symptoms in patients with advanced cancer. This trial will test a brief telehealth delivered psychosocial intervention called ENGAGE. ENGAGE aims to help patients decrease symptom interference and improve their quality of life. Patients with Stage IV cancer (breast, prostate, lung, or colorectal) and moderate-to-severe symptom interference will be randomized to ENGAGE or Supportive Care. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months. Aim 1 is to determine ENGAGE's efficacy for reducing symptom interference (primary outcome) at 2 months (primary endpoint). Aim 2 is to determine ENGAGE's efficacy for improving secondary outcomes at 2 months. Aim 3 is to test the maintenance of ENGAGE's effects on primary and secondary outcomes at 4 months. An exploratory aim seeks insights for future implementation efforts using mixed-methods data collection from patients, oncology providers, and clinic leaders.
Arms & interventions
- BehavioralENGAGE
This intervention is delivered by trained therapists over four, 45-60 minute, manualized telehealth sessions. The session content is based on an integration of Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) approaches for managing symptoms of pain, fatigue, and distress. Participants are trained in behavioral symptom management skills (e.g., activity pacing, mindfulness) with an emphasis on engaging in highly valued activities.
- BehavioralSupportive Care
This intervention is delivered by trained therapists over four, 45-60 minute, manualized telehealth sessions. The session content is designed to provide participants with education, support, and resources for a range of issues relevant to those with advanced cancer (e.g., education on symptoms, body image concerns, and financial concerns).
Outcome measures
Primary
MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale
This measure assesses the degree to which, over the past 7 days, symptoms of pain, fatigue, and/or distress have interfered with patients' general activity, mood, work (including work around the house), relations with other people, walking, and enjoyment of life. Items are scored from 0 = "Did not interfere" to 10 = "Interfered completely," and averaged for a composite score.
Time frame: 2 months
Secondary
MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale
Time frame: 4 months
MD Anderson Symptom Inventory (MDASI) Symptom Severity Scale
Time frame: 2 months and 4 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Symptoms
Time frame: 2 months and 4 months
Openness to Experience subscale of the Comprehensive Assessment of Acceptance and Commitment Therapy (CompACT)
Time frame: 2 months and 4 months
Behavioral Awareness subscale of the Comprehensive Assessment of Acceptance and Commitment Therapy (CompACT)
Time frame: 2 months and 4 months
Valued Action subscale of the Comprehensive Assessment of Acceptance and Commitment Therapy (CompACT)
Time frame: 2 months and 4 months
Brief Pain Inventory (BPI)
Time frame: 2 months and 4 months
Brief Fatigue Inventory (BFI)
Time frame: 2 months and 4 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety-Short Form
Time frame: 2 months and 4 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression-Short Form
Time frame: 2 months and 4 months
Functional Assessment of Cancer Therapy-General (FACT-G)
Time frame: 2 months and 4 months
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp)
Time frame: 2 months and 4 months
Eligibility criteria
Study locations (1)
Duke Cancer Network
Durham, North Carolina, 27713
References
- Winger JG, Kelleher SA, Yu JA, Ma JE, Majestic CM, Martinson EB, Olsen MK, Lerebours R, Sutton LM, Somers TJ. Engage: Protocol of a randomized controlled trial of a telehealth-delivered psychosocial intervention to decrease symptom interference in patients with advanced cancer. Contemp Clin Trials. 2025 Sep;156:108053. doi: 10.1016/j.cct.2025.108053. Epub 2025 Aug 18.(PubMed)